Cathie Wood’s ARK Invest Buys Over 1 Million Shares of Iovance Bio

A couple of the ARK exchange-traded funds run by ETF star Cathie Wood made huge purchases on Thursday. These funds bought over 1 million shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares on Thursday, as the price of these ETFs rose around 3% on Thursday. Note that these ETFs are still up handily in the last year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 201,664 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 808,642 shares of Iovance. At Thursday’s closing price this would have valued this purchase at $18.9 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 65%, and ARKK is up 75% in the last year.

Check out all of ARK Invest’s buys for Thursday:

FundTickerCompanyShares
ARKFCOINCOINBASE GLOBAL INC38,220
ARKFKSPILIKASPI.KZ JSC4,436
ARKGRXRXRECURSION PHARMACEUTICALS INC14,440
ARKGONEM1LIFE HEALTHCARE INC144,563
ARKGSGFYSIGNIFY HEALTH INC139,900
ARKGIOVAIOVANCE BIOTHERAPEUTICS INC201,664
ARKGCSTLCASTLE BIOSCIENCES INC11,536
ARKGCMIIUCM LIFE SCIENCES II INC305
ARKGCDXSCODEXIS INC1,929
ARKGMASS908 DEVICES INC13,080
ARKGRPTXREPARE THERAPEUTICS INC41,780
ARKKPACBPACIFIC BIOSCIENCES OF CALIFORNIA INC7,496
ARKKIOVAIOVANCE BIOTHERAPEUTICS INC808,642
ARKKEXASEXACT SCIENCES CORP125,929
ARKKCOINCOINBASE GLOBAL INC216,518
ARKKBEAMBEAM THERAPEUTICS INC30,000
ARKQACICATLAS CREST INVESTMENT CORP421,940
ARKQPATHUIPATH INC6,131
ARKQNIUNIU TECHNOLOGIES125,271
ARKXBLDEBLADE AIR MOBILITY INC105,037

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

ALSO READ: Semiconductor Equipment Sell-Off Overdone: Jump on These 5 Stocks Now


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article